FDA OKs CardioDynamics third-generation heart monitor:
This article was originally published in Clinica
Executive Summary
The US FDA has given CardioDynamics 510(k) clearance to market its third-generation impedance cardiography (ICG)-based product for monitoring the heart in a noninvasive fashion. The BioZ Dx system represents the first phase of a co-development partnership between the San Diego, California company and Philips Medical Systems; following its immediate release into the market, BioZ Dx will be upgradeable to include Philips' 12-lead ECG technology in late 2005.